annual FCF:
-$40.69M-$17.31M(-74.02%)Summary
- As of today (September 15, 2025), AKBA annual free cash flow is -$40.69 million, with the most recent change of -$17.31 million (-74.02%) on December 31, 2024.
- During the last 3 years, AKBA annual FCF has risen by +$212.33 million (+83.92%).
- AKBA annual FCF is now -173.66% below its all-time high of $55.24 million, reached on December 31, 2016.
Performance
AKBA Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$22.22M+$35.82M(+263.31%)Summary
- As of today (September 15, 2025), AKBA quarterly free cash flow is $22.22 million, with the most recent change of +$35.82 million (+263.31%) on June 1, 2025.
- Over the past year, AKBA quarterly FCF has increased by +$32.31 million (+320.10%).
- AKBA quarterly FCF is now -76.76% below its all-time high of $95.62 million, reached on December 31, 2016.
Performance
AKBA quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$2.55M+$32.31M(+92.68%)Summary
- As of today (September 15, 2025), AKBA TTM free cash flow is -$2.55 million, with the most recent change of +$32.31 million (+92.68%) on June 1, 2025.
- Over the past year, AKBA TTM FCF has increased by +$36.45 million (+93.46%).
- AKBA TTM FCF is now -103.17% below its all-time high of $80.38 million, reached on June 30, 2017.
Performance
AKBA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AKBA Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -74.0% | +320.1% | +93.5% |
| 3 y3 years | +83.9% | +172.5% | +98.5% |
| 5 y5 years | +84.6% | -40.2% | +98.1% |
AKBA Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -74.0% | +83.9% | -34.3% | +140.6% | at high | +98.5% |
| 5 y | 5-year | -74.0% | +84.6% | -40.2% | +131.4% | at high | +99.0% |
| alltime | all time | -173.7% | +84.6% | -76.8% | +115.9% | -103.2% | +99.0% |
AKBA Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $22.22M(-263.3%) | -$2.55M(-92.7%) |
| Mar 2025 | - | -$13.61M(+204.5%) | -$34.87M(-14.3%) |
| Dec 2024 | -$40.69M(+74.0%) | -$4.47M(-33.3%) | -$40.69M(+5.6%) |
| Sep 2024 | - | -$6.70M(-33.7%) | -$38.53M(-1.2%) |
| Jun 2024 | - | -$10.10M(-48.0%) | -$39.00M(+54.3%) |
| Mar 2024 | - | -$19.43M(+741.9%) | -$25.28M(+8.1%) |
| Dec 2023 | -$23.38M(-68.1%) | -$2.31M(-67.8%) | -$23.38M(-69.1%) |
| Sep 2023 | - | -$7.17M(-297.5%) | -$75.75M(+117.8%) |
| Jun 2023 | - | $3.63M(-120.7%) | -$34.78M(-49.6%) |
| Mar 2023 | - | -$17.54M(-67.9%) | -$69.07M(-5.7%) |
| Dec 2022 | -$73.27M(-71.0%) | -$54.68M(-261.7%) | -$73.27M(-10.0%) |
| Sep 2022 | - | $33.80M(-210.3%) | -$81.40M(-52.5%) |
| Jun 2022 | - | -$30.66M(+41.1%) | -$171.47M(-15.9%) |
| Mar 2022 | - | -$21.73M(-65.4%) | -$203.95M(-19.4%) |
| Dec 2021 | -$253.02M(+128.6%) | -$62.81M(+11.6%) | -$253.02M(+14.3%) |
| Sep 2021 | - | -$56.27M(-10.9%) | -$221.31M(+15.1%) |
| Jun 2021 | - | -$63.14M(-10.8%) | -$192.24M(+109.1%) |
| Mar 2021 | - | -$70.81M(+127.7%) | -$91.92M(-17.0%) |
| Dec 2020 | -$110.70M(-58.1%) | -$31.10M(+14.4%) | -$110.70M(-35.6%) |
| Sep 2020 | - | -$27.19M(-173.1%) | -$171.96M(+26.2%) |
| Jun 2020 | - | $37.17M(-141.5%) | -$136.31M(-36.3%) |
| Mar 2020 | - | -$89.59M(-3.0%) | -$213.83M(-19.0%) |
| Dec 2019 | -$264.10M(+166.5%) | -$92.36M(-1191.7%) | -$264.10M(+7.2%) |
| Sep 2019 | - | $8.46M(-121.0%) | -$246.27M(-7.9%) |
| Jun 2019 | - | -$40.34M(-71.2%) | -$267.50M(+22.5%) |
| Mar 2019 | - | -$139.86M(+87.7%) | -$218.33M(+120.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$99.10M(+71.5%) | -$74.53M(+483.7%) | -$99.10M(+139.4%) |
| Sep 2018 | - | -$12.77M(-244.7%) | -$41.40M(-50.6%) |
| Jun 2018 | - | $8.82M(-142.8%) | -$83.84M(+22.5%) |
| Mar 2018 | - | -$20.63M(+22.6%) | -$68.45M(+18.5%) |
| Dec 2017 | -$57.78M(-204.6%) | -$16.83M(-69.5%) | -$57.78M(-205.7%) |
| Sep 2017 | - | -$55.21M(-328.0%) | $54.67M(-32.0%) |
| Jun 2017 | - | $24.22M(-343.3%) | $80.38M(+187.5%) |
| Mar 2017 | - | -$9.96M(-110.4%) | $27.96M(-49.4%) |
| Dec 2016 | $55.24M(-204.6%) | $95.62M(-424.2%) | $55.24M(-187.2%) |
| Sep 2016 | - | -$29.50M(+4.6%) | -$63.36M(+47.3%) |
| Jun 2016 | - | -$28.20M(-262.8%) | -$43.01M(+59.6%) |
| Mar 2016 | - | $17.32M(-175.4%) | -$26.95M(-49.0%) |
| Dec 2015 | -$52.82M(+90.6%) | -$22.98M(+151.3%) | -$52.82M(+35.2%) |
| Sep 2015 | - | -$9.15M(-24.7%) | -$39.06M(+9.9%) |
| Jun 2015 | - | -$12.14M(+42.1%) | -$35.56M(+18.1%) |
| Mar 2015 | - | -$8.55M(-7.3%) | -$30.11M(+8.7%) |
| Dec 2014 | -$27.71M(+144.1%) | -$9.22M(+63.5%) | -$27.71M(+18.4%) |
| Sep 2014 | - | -$5.64M(-15.8%) | -$23.41M(+13.0%) |
| Jun 2014 | - | -$6.70M(+8.9%) | -$20.71M(+29.7%) |
| Mar 2014 | - | -$6.15M(+25.0%) | -$15.97M(+40.7%) |
| Dec 2013 | -$11.35M(+57.4%) | -$4.92M(+67.2%) | -$11.35M(+76.5%) |
| Sep 2013 | - | -$2.94M(+50.4%) | -$6.43M(+84.4%) |
| Jun 2013 | - | -$1.96M(+27.9%) | -$3.49M(+127.9%) |
| Mar 2013 | - | -$1.53M | -$1.53M |
| Dec 2012 | -$7.21M(-49.2%) | - | - |
| Dec 2011 | -$14.18M | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual free cash flow?
- What is the all time high annual FCF for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual FCF year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly FCF year-on-year change?
- What is Akebia Therapeutics, Inc. TTM free cash flow?
- What is the all time high TTM FCF for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM FCF year-on-year change?
What is Akebia Therapeutics, Inc. annual free cash flow?
The current annual FCF of AKBA is -$40.69M
What is the all time high annual FCF for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual free cash flow is $55.24M
What is Akebia Therapeutics, Inc. annual FCF year-on-year change?
Over the past year, AKBA annual free cash flow has changed by -$17.31M (-74.02%)
What is Akebia Therapeutics, Inc. quarterly free cash flow?
The current quarterly FCF of AKBA is $22.22M
What is the all time high quarterly FCF for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly free cash flow is $95.62M
What is Akebia Therapeutics, Inc. quarterly FCF year-on-year change?
Over the past year, AKBA quarterly free cash flow has changed by +$32.31M (+320.10%)
What is Akebia Therapeutics, Inc. TTM free cash flow?
The current TTM FCF of AKBA is -$2.55M
What is the all time high TTM FCF for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM free cash flow is $80.38M
What is Akebia Therapeutics, Inc. TTM FCF year-on-year change?
Over the past year, AKBA TTM free cash flow has changed by +$36.45M (+93.46%)